Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Cytek Biosciences IncCommon Stock stock | $23.3

Learn how to easily invest in Cytek Biosciences IncCommon Stock stock.

Cytek Biosciences Inc. Common Stock is a medical devices business based in the US. Cytek Biosciences IncCommon Stock shares (CTKB) are listed on the NASDAQ and all prices are listed in US Dollars. Cytek Biosciences IncCommon Stock employs 429 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Cytek Biosciences IncCommon Stock

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CTKB – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Cytek Biosciences IncCommon Stock stock price (NASDAQ: CTKB)

Use our graph to track the performance of CTKB stocks over time.

Cytek Biosciences IncCommon Stock shares at a glance

Information last updated 2021-10-26.
Latest market close$23.30
52-week range$17.00 - $28.70
50-day moving average $23.96
200-day moving average $23.34
Wall St. target price$27.00
PE ratio 436.3637
Dividend yield N/A (0%)
Earnings per share (TTM) $0.06

Buy Cytek Biosciences IncCommon Stock shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Robinhood
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
TradeStation
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$50
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Moomoo
Stocks
$0
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Webull
Stocks, Options, ETFs
$0
0%
Get two free stocks valued between $3.00 and $300 with a deposit to any new account.
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Cytek Biosciences IncCommon Stock stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Cytek Biosciences IncCommon Stock price performance over time

Historical closes compared with the close of $23.3 from 2021-10-27

1 week (2021-10-21) -2.63%
1 month (2021-09-28) 3.51%
3 months (2021-07-28) 17.38%
6 months (2021-04-24) N/A
1 year (2020-10-24) N/A
2 years (2019-10-24) N/A
3 years (2018-10-24) N/A
5 years (2016-10-24) N/A

Is Cytek Biosciences IncCommon Stock under- or over-valued?

Valuing Cytek Biosciences IncCommon Stock stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Cytek Biosciences IncCommon Stock's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Cytek Biosciences IncCommon Stock's P/E ratio

Cytek Biosciences IncCommon Stock's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 436x. In other words, Cytek Biosciences IncCommon Stock shares trade at around 436x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

However, Cytek Biosciences IncCommon Stock's P/E ratio is best considered in relation to those of others within the medical devices industry or those of similar companies.

    Cytek Biosciences IncCommon Stock's EBITDA

    Cytek Biosciences IncCommon Stock's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $20.2 million.

    The EBITDA is a measure of a Cytek Biosciences IncCommon Stock's overall financial performance and is widely used to measure a its profitability.

    To put Cytek Biosciences IncCommon Stock's EBITDA into context you can compare it against that of similar companies.

    Cytek Biosciences IncCommon Stock financials

    Revenue TTM $110.4 million
    Operating margin TTM 17.69%
    Gross profit TTM $51.7 million
    Return on assets TTM 0%
    Return on equity TTM 0%
    Profit margin 13.51%
    Book value N/A
    Market capitalisation $3.2 billion

    TTM: trailing 12 months

    Shorting Cytek Biosciences IncCommon Stock shares

    There are currently 588,524 Cytek Biosciences IncCommon Stock shares held short by investors – that's known as Cytek Biosciences IncCommon Stock's "short interest". This figure is 206.3% up from 192,169 last month.

    There are a few different ways that this level of interest in shorting Cytek Biosciences IncCommon Stock shares can be evaluated.

    Cytek Biosciences IncCommon Stock's "short interest ratio" (SIR)

    Cytek Biosciences IncCommon Stock's "short interest ratio" (SIR) is the quantity of Cytek Biosciences IncCommon Stock shares currently shorted divided by the average quantity of Cytek Biosciences IncCommon Stock shares traded daily (recently around 426466.66666667). Cytek Biosciences IncCommon Stock's SIR currently stands at 1.38. In other words for every 100,000 Cytek Biosciences IncCommon Stock shares traded daily on the market, roughly 1380 shares are currently held short.

    To gain some more context, you can compare Cytek Biosciences IncCommon Stock's short interest ratio against those of similar companies.

    However Cytek Biosciences IncCommon Stock's short interest can also be evaluated against the total number of Cytek Biosciences IncCommon Stock shares, or, against the total number of tradable Cytek Biosciences IncCommon Stock shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Cytek Biosciences IncCommon Stock's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Cytek Biosciences IncCommon Stock shares in existence, roughly 0 shares are currently held short) or 0.0057% of the tradable shares (for every 100,000 tradable Cytek Biosciences IncCommon Stock shares, roughly 6 shares are currently held short).

    Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Cytek Biosciences IncCommon Stock.

    Find out more about how you can short Cytek Biosciences IncCommon Stock stock.

    Cytek Biosciences IncCommon Stock share dividends

    We're not expecting Cytek Biosciences IncCommon Stock to pay a dividend over the next 12 months.

    Cytek Biosciences IncCommon Stock overview

    Cytek Biosciences, Inc. engages in the manufacture and sale of cell analysis solutions for clinical and biomedical research in the fields of drug discovery, genomics, immuno-oncology, immuno-profiling, infectious diseases, inflammatory diseases, and multi-site standardization applications. Its instruments include the Aurora and Northern Lights systems, which are flow cytometers to deliver cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. The company also offers cFluor reagents, which are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments. Its customers include pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. The company distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific region; and through distributors or sales agents in European, Latin American, the Middle Eastern, and the Asia-Pacific countries. Cytek Biosciences, Inc.

    Frequently asked questions

    What percentage of Cytek Biosciences IncCommon Stock is owned by insiders or institutions?
    Currently 12.054% of Cytek Biosciences IncCommon Stock shares are held by insiders and 9.27% by institutions.
    How many people work for Cytek Biosciences IncCommon Stock?
    Latest data suggests 429 work at Cytek Biosciences IncCommon Stock.
    When does the fiscal year end for Cytek Biosciences IncCommon Stock?
    Cytek Biosciences IncCommon Stock's fiscal year ends in December.
    Where is Cytek Biosciences IncCommon Stock based?
    Cytek Biosciences IncCommon Stock's address is: 46107 Landing Parkway, Fremont, CA, United States, 94538
    What is Cytek Biosciences IncCommon Stock's ISIN number?
    Cytek Biosciences IncCommon Stock's international securities identification number is: US23285D1090

    More guides on Finder

    Ask an Expert

    You are about to post a question on finder.com:

    • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
    • finder.com is a financial comparison and information service, not a bank or product provider
    • We cannot provide you with personal advice or recommendations
    • Your answer might already be waiting – check previous questions below to see if yours has already been asked

    Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

    By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

    Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
    Go to site